Healthcare Business

pills

Drugmakers Merck, Pfizer Eke Out Profit Hikes

Drug giant Merck & Co. Inc. (NYSE: MRK) reported second-quarter 2014 results before markets opened Tuesday. The company posted quarterly adjusted diluted earnings per share (EPS) of $0.85 and revenues ...
Read Full Story »
Pills

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie Inc. (NYSE: ABBV) reported second-quarter 2014 results before markets opened Friday. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.82 on revenues of $4.93 billion. ...
Read Full Story »
DNA

You Just Won’t Believe Gilead’s Profit Margins

Gilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings of $2.36 per share ($3.93 billion) on more than a ...
Read Full Story »
95992888

Is Puma Biotech For Real, Again?

Puma Biotechnology Inc. (NYSE: PBYI) has just defied all odds in biotech. The stock has risen more than 200% in a single day, and its market cap magically jumped from ...
Read Full Story »
Botox injection

Allergan Chops 1,500 Jobs to Fend Off Valeant

Allergan Inc. (NYSE: AGN) reported second-quarter 2014 results before markets opened Monday. The Botox-maker posted adjusted diluted earnings per share (EPS) of $1.51 on revenues of $1.85 billion. In the ...
Read Full Story »
145922793

Valeant Offer Weaker After Allergan Earnings

Botox-maker Allergan Inc. (NYSE: AGN) released second-quarter earnings Monday morning about an hour after Valeant Pharmaceuticals International Inc. (NYSE: VRX) slammed Allergan for misleading statements about Valeant's Bausch & Lomb ...
Read Full Story »
Comfortable hospital bed

Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks

With the second-quarter earnings coming fast and furious, and with another big week in front of investors, many of the top Wall Street firms that we cover are getting the ...
Read Full Story »
Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
research

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

For the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street has loudly stepped up to the plate and advised investors ...
Read Full Story »
biotech

4 Key Positive Biotech Stock Catalysts Coming Very Soon

Investors and speculators often flock to the world biotech for emerging drugs of the future. It is no secret at all that the biotech sector is full of all sorts ...
Read Full Story »
Biotechnology word cloud

4 Top Biotechs Expected to Beat Earnings Expectations

With earning season just starting to be in full gear, everybody on Wall Street is looking for the earnings angle, and it seems like almost every firm we cover here ...
Read Full Story »
research

Why the Exelixis Cancer Trial News Matters This Time

Cancer treatment developer Exelixis Inc. (NASDAQ: EXEL) is trading very heavy volume today and getting a sharp price boost following a positive result in a phase 3 pivotal trial of ...
Read Full Story »
Abbott Laboratories Logo

Abbott, Mylan Join Forces to Dodge U.S. Taxes

Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Abbott Laboratories (NYSE: ABT) has agreed to sell its non-U.S. generic drug business ...
Read Full Story »
Biotechnology word cloud

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

After the biotech stocks were absolutely crushed in the late winter and early spring, many of the top firms we cover on Wall Street were aggressive in their calls to ...
Read Full Story »
DNA

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

Binary events are often the key element in moving a biotech or health care stock higher. Negative binary results or actions often can move shares drastically lower. We scan our ...
Read Full Story »